569 related articles for article (PubMed ID: 16513057)
1. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
Lund AM
Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
[TBL] [Abstract][Full Text] [Related]
2. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
[TBL] [Abstract][Full Text] [Related]
3. The Ehlers-Danlos syndromes.
Yeowell HN; Pinnell SR
Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
[TBL] [Abstract][Full Text] [Related]
4. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
[TBL] [Abstract][Full Text] [Related]
5. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
[TBL] [Abstract][Full Text] [Related]
6. Ehlers-Danlos syndromes and Marfan syndrome.
Callewaert B; Malfait F; Loeys B; De Paepe A
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
[TBL] [Abstract][Full Text] [Related]
7. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders.
De Paepe A; Malfait F
Br J Haematol; 2004 Dec; 127(5):491-500. PubMed ID: 15566352
[TBL] [Abstract][Full Text] [Related]
8. [Ehlers-Danlos syndrome--diagnosis and subclassification].
Rand-Hendriksen S; Wekre LL; Paus B
Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1903-7. PubMed ID: 16915311
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
[TBL] [Abstract][Full Text] [Related]
10. Absence of inferior labial and lingual frenula in Ehlers-Danlos syndrome: a minor diagnostic criterion in French patients.
Machet L; Hüttenberger B; Georgesco G; Doré C; Jamet F; Bonnin-Goga B; Giraudeau B; Maruani A; Laure B; Vaillant L
Am J Clin Dermatol; 2010; 11(4):269-73. PubMed ID: 20143893
[TBL] [Abstract][Full Text] [Related]
11. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
[TBL] [Abstract][Full Text] [Related]
12. The Ehlers-Danlos syndrome, a disorder with many faces.
De Paepe A; Malfait F
Clin Genet; 2012 Jul; 82(1):1-11. PubMed ID: 22353005
[TBL] [Abstract][Full Text] [Related]
13. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito.
Toriello HV; Glover TW; Takahara K; Byers PH; Miller DE; Higgins JV; Greenspan DS
Nat Genet; 1996 Jul; 13(3):361-5. PubMed ID: 8673139
[TBL] [Abstract][Full Text] [Related]
14. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
[TBL] [Abstract][Full Text] [Related]
15. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.
Walker LC; Teebi AS; Marini JC; De Paepe A; Malfait F; Atsawasuwan P; Yamauchi M; Yeowell HN
Mol Genet Metab; 2004 Dec; 83(4):312-21. PubMed ID: 15589118
[TBL] [Abstract][Full Text] [Related]
17. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
[TBL] [Abstract][Full Text] [Related]
18. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
[TBL] [Abstract][Full Text] [Related]
19. Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.
Beridze N; Frishman WH
Cardiol Rev; 2012; 20(1):4-7. PubMed ID: 22143279
[TBL] [Abstract][Full Text] [Related]
20. [Ehlers-Danlos syndromes. Clinical, genetic and molecular aspects].
Germain D
Ann Dermatol Venereol; 1995; 122(4):187-204. PubMed ID: 8526413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
